000 | 03003nam a22005777a 4500 | ||
---|---|---|---|
001 | sulb-eb0025837 | ||
003 | BD-SySUS | ||
005 | 20160413122548.0 | ||
007 | cr nn 008mamaa | ||
008 | 130413s2013 au | s |||| 0|eng d | ||
020 |
_a9783709113684 _9978-3-7091-1368-4 |
||
024 | 7 |
_a10.1007/978-3-7091-1368-4 _2doi |
|
050 | 4 | _aRM1-950 | |
072 | 7 |
_aMMG _2bicssc |
|
072 | 7 |
_aMED071000 _2bisacsh |
|
082 | 0 | 4 |
_a615 _223 |
245 | 1 | 0 |
_aSphingolipids: Basic Science and Drug Development _h[electronic resource] / _cedited by Erich Gulbins, Irina Petrache. |
264 | 1 |
_aVienna : _bSpringer Vienna : _bImprint: Springer, _c2013. |
|
300 |
_aVIII, 259 p. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v215 |
|
505 | 0 | _aPreface -- Part 1. Basic mechanisms -- Part 2. Drug development. | |
520 | _aSphingolipids are lipid components of the plasma membrane in eukaryotic cells. They have an important function in signaling mechanisms in the cell. This book on sphingolipids provides insights into the basics of sphingolipid biology and drug development, with a particular emphasis on the sphingolipid derivative ceramide. In the first part basic functions of sphingolipids are described, as well as the genetics of important enzymes, sphingolipid metabolism and synthesis. The second part of this first volume focuses on drug development and pharmacology. The book is intended for scientists in pharmacology, biochemistry and cell biology with a focus on biomedical research as well as for clinicians working in pharmacology, oncology, cardiology, neurology and infectious disease. Together with Volume 216 by the same editors, the collection represents a unique, comprehensive work on sphingolipids, providing information on both sphingolipids’ basic biology (including synthesis, metabolism and cell biology) and their important function in a (patho-)physiological context. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aCancer research. | |
650 | 0 | _aMolecular biology. | |
650 | 0 | _aPharmacology. | |
650 | 0 | _aOncology. | |
650 | 0 | _aCell biology. | |
650 | 0 | _aCell membranes. | |
650 | 1 | 4 | _aBiomedicine. |
650 | 2 | 4 | _aPharmacology/Toxicology. |
650 | 2 | 4 | _aMembrane Biology. |
650 | 2 | 4 | _aCancer Research. |
650 | 2 | 4 | _aMolecular Medicine. |
650 | 2 | 4 | _aCell Biology. |
650 | 2 | 4 | _aOncology. |
700 | 1 |
_aGulbins, Erich. _eeditor. |
|
700 | 1 |
_aPetrache, Irina. _eeditor. |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9783709113677 |
830 | 0 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v215 |
|
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-7091-1368-4 |
912 | _aZDB-2-SBL | ||
942 |
_2Dewey Decimal Classification _ceBooks |
||
999 |
_c47929 _d47929 |